Physician profile
Guy J Manetti
NPI 1720246333
$7,229.28
in general payments reported to CMS, 2019-2025
55 companies · $1,373 in 2025
The $1,373 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,711 · 2020: $398 · 2021: $655 · 2022: $901 · 2023: $772 · 2024: $1,419 · 2025: $1,373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,485 · Education: $77.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,485.36 |
| Education | $77.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $792.80 | 2020-2025 | Jelmyto |
| Astellas Pharma US INC | $681.31 | 2019-2025 | Veozah, Xtandi |
| Coloplast Corp | $642.03 | 2019-2025 | |
| Karl Storz Endoscopy-America | $410.63 | 2019-2025 | N.A., Hd-View, Flex-X / Image 1 S |
| Sumitomo Pharma America, INC. | $310.18 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $301.73 | 2023-2025 | |
| Teleflex LLC | $301.63 | 2022-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $283.64 | 2019-2025 | Rezum Generator, Lithovue |
| Myovant Sciences INC. | $269.98 | 2021-2022 | |
| Pfizer INC. | $267.27 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $253.94 | 2019-2024 | Aveed, Edex, Xiaflex |
| Amgen INC. | $244.81 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $225.31 | 2020-2025 | Keytruda, Lynparza, Welireg |
| Janssen Biotech, INC. | $163.06 | 2019-2025 | Erleada |
| Progenics Pharmaceuticals, INC. | $157.65 | 2021-2024 | Pylarify |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guy Manetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.